Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 4 ppsx
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 4 ppsx
... lack of experience and lack of
prospective studies and protocols);
4 clear and accurate patient selection, criteria, indica-
tions, approaches, limitations, and advantages and dis-
advantages, in ... 2000;1 14: 444 44 8.
Banciu T, Susan L, Jovin G, Sporea I, Vacariu V. Prevalence of
chronic (latent) pancreatitis in hospitalized chronic con-
sumers of alcohol. Rom J Intern Med 1991...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 2 pptx
... present-
ing with fluid collections (Figs 7 .4 7.7). Combined
mortality for patients with grades D and E was 14%
and morbidity was 54% , compared with no mortality
and a morbidity rate of only 4% in ... thicken peritoneal sur-
faces, involve the mesocolon and small-bowel mesen-
tery, enter the peritoneal cavity and present as ascites,
PART I
60
Figure 7.2 Normal pancreas in a 70...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 3 doc
... Conventional
UK 4 (12) 4 (12) 0 (0) 0 (0) 34 34
Hong Kong 6 (18) 6 (17) 0 (0) 0 (0) 34 35
Germany 35 (42 ) 36 (47 ) 2 (2) 0 (0) 84 76
Poland 8 (10) 19 (25) 0 (0) 4 (5) 53 65
All 53 (23) 65 (30) 2 (0) 4 (2) ... Conventional
UK 6 ( 24) 17 (61) 1 (4) 5 (18) 25 28
Hong Kong 4 (13) 15 ( 54) 1 (3) 5 (18) 30 28
Germany 17 (65) 14 (70) 6 (23) 2 (10) 26 20
Poland 9 (39) 20 ( 74) 1 (4) 9...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 5 potx
... gene.
T
n
9
7
5
(TG)
m
9
11
10
12
13
(TG)
m
–T
n
9-9
1 0-9
1 1-9
1 0-7
1 1-7
1 2-7
1 1-5
1 2-5
1 3-5
Figure 25.3 Effect of particular alleles on the amount
of functional CFTR. For different polymorphic loci (T
n
and TG
m
) or haplotypes (TG
m
-T
n
), ... gold
standard for the morphologic diagnosis of chronic pan-
creatitis, the wide and accurate informatio...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 6 pptx
... 100 46 83 14 23
Costamagna et al. 1997 35 100 74 72 3 27
Adamek et al. 1999 80 54 ND 76 10 40
Brand et al. 2000 48 60 44 82 4 7
Farnbacher et al. 2002 125 85 64 48* 13 29
Kozarek et al. 2002 40 ... achieve stone fragmentation in 54 100% of
cases, complete duct clearance in 44 – 74% , and com-
plete or partial pain relief in 48 –85% after a mean
follow-up of 7 40 months; surge...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 7 pdf
... HER3
Amphiregulin HER4
Betacellulin
HB-EGF
Epiregulin
Fibroblast growth factor (FGF) family FGF-1 FGFR-1
FGF-2 FGFR-2
KGF FGFR-3
FGFR -4
Insulin-like growth factor (IGF) family IGF-I IRS-1
IGF-II IRS-2
Hepatocyte ... (NGF) family NGF TrkA
Transforming growth factor (TGF)-b family TGF-b1TbRI
TGF-b2TbRII
TGF-b3TbRIII
Activin-bA actRI/Ib
Activin-bB actRII
Inhibin-a BMPR-IA
BMP-2 BMPR-II
Urokin...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 8 potx
... serum CA-1 9-9 levels. The sen-
sitivity of the CA-1 9-9 serum assay ranges between 69
and 93%, the specificity between 46 and 98%. The
higher the level of CA-1 9-9 , the greater the sensitivity
and specificity ... signs of al-
tered islet cell differentiation, including the formation
of intrainsular ductular structures and the expression
of tumor-associated antigens CA-1 9-9 ,...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 9 doc
... FAM 24
Bakkevold et al.* 1993 31 ( 24 PDAC)
—
11 45 30 8
30 (23 PDAC) FAM 23 70 27 4
Baumel et al. 19 94 527
—
12 .4
43 Various 11.5
Neoptolemos et al.* 2001–20 04 237
—
14. 8 28.7 9.9
244 5-FU/FA ... the control group (13.5 months and
PART III
44 8
Organisation for Research and Treatment of Cancer QLQ-
C30: a quality-of-life instrument for use in international
clinical...
Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 10 pptx
... 109
chemoradiotherapy
adjuvant 44 6, 44 7, 44 8
with maintenance chemotherapy 44 8, 44 9, 45 0
survival 45 0
combined for locally advanced disease 46 8–9
chemotherapy
adjuvant
regional 44 6
systemic 44 4–6
aggressive neoadjuvant 42 3
combination ... therapy 363 4
hereditary 3 64
cyclic adenosine monophosphate (cAMP) 21–2
adjuvant therapy
postoperative radiochemotherapy 44 1–2...
Expert Systems for Human Materials and Automation Part 4 potx
... Addison-Wesley,
ISBN 0-2 0 1-5 030 5-0 , New York
Weiser, M. (1991), The Computer for the Twenty-First Century. In: Scientific American,
Vol.265, No.3, (September 1991), pp.9 4- 1 04, ISSN 003 6-8 733
7
Advances ... (eds.), pp.1 1 -4 3, Addison-Wesley, ISBN 0-
20 1-5 030 5-0 , New York
Netto, A. (20 04) . IHC: Modelagem e Gerência de Interfaces com o Usuário, Visual B...